DEF: Tharimmune Seeks Shareholder Approval for Strategic Shift

Tharimmune, Inc. calls a special meeting to vote on new directors, significant equity issuances for strategic advisors and private placements, and an expansion of its equity incentive plan.

Summary

• A special meeting of stockholders will be held on January 30, 2026, to vote on six key proposals.
• Proposals include the election of two new directors, Jill E. Sommers and William Wiley, to the Board of Directors, with James Gordon Liddy resigning upon their approval.
• Shareholder approval is sought for the issuance of common stock upon the exercise of Strategic Advisor Warrants, representing 5.0% of the aggregate fully diluted common stock from an offering, with an exercise price of $0.001.
• Approval is also requested for the issuance of common stock upon the exercise of Cryptocurrency Pre-Funded Warrants, issued in connection with a private placement offering where Canton Coin cryptocurrency was accepted as consideration, with an exercise price of $0.0001.
• Stockholders will vote on the issuance of 162,601 Advisor RSUs and underlying shares of common stock to Clear Street LLC, the placement agent for a private placement offering.
• A significant proposal is to amend the 2023 Omnibus Equity Incentive Plan to increase the number of shares available for issuance by 7,000,000, bringing the total to 9,000,000 shares.
• The Board unanimously recommends voting FOR the election of each director nominee and FOR Proposals 2, 3, 4, and 5, and for authorizing adjournments if needed.

Sentiment

Score: 4

Explanation: The filing outlines a significant strategic pivot into cryptocurrency and digital assets, supported by new board members with relevant expertise, which could be a positive long-term growth driver. However, the proposals involve substantial potential dilution from warrants, RSUs, and a large increase in the equity incentive plan, alongside significant cash bonuses to executives related to recent capital raises. These factors present a mixed outlook, with the dilution and executive compensation raising concerns for existing shareholders.

Positives

• The Board is being strengthened with the nomination of two new directors, Jill E. Sommers and William Wiley, who bring extensive experience in derivatives regulation, financial markets, capital markets, and business strategy.
• Formal corporate governance practices are in place, including a majority of independent directors on the Board and its key committees, enhancing oversight and accountability.
• A Policy for the Recovery of Erroneously Awarded Compensation (Clawback Policy) has been adopted, effective October 2, 2023, aligning with Nasdaq listing standards and improving corporate accountability.
• The company is pursuing a strategic expansion and diversification into cryptocurrency and digital asset strategies, potentially opening new growth avenues and market opportunities.

Negatives

• There is significant potential dilution from the proposed issuance of shares upon the exercise of Strategic Advisor Warrants (5.0% of fully diluted common stock from an offering), Cryptocurrency Pre-Funded Warrants, and Advisor RSUs (162,601 shares).
• The proposed increase of 7,000,000 shares to the 2023 Omnibus Equity Incentive Plan, bringing the total to 9,000,000 shares, could lead to substantial further dilution for existing shareholders.
• Substantial cash bonuses were paid in connection with the November PIPE, including $2.05 million to the Chairman of the Board and $1.9 million to the prior Interim Chief Financial Officer.
• Related party transactions are disclosed, where current executives and directors participated in private placements and are affiliated with strategic advisors receiving warrants, raising potential conflict of interest concerns.

Risks

• Failure to obtain stockholder approval for Proposals 2, 3, 4, or 5 could prevent the exercise of warrants/settlement of RSUs, potentially impacting the company's ability to fulfill its obligations and implement its strategic initiatives.
• If the amendment to the 2023 Equity Incentive Plan (Proposal 5) is not approved, the company may be compelled to significantly increase the cash component of its employee and director compensation, which could increase cash compensation expense and use cash that could be better utilized.
• The company's strategic shift into cryptocurrency and digital asset strategies introduces new market volatility, regulatory uncertainty, and operational risks inherent in the digital asset sector.
• The Strategic Advisor Warrants are non-transferable and subject to a 180-day lock-up period, which could affect the liquidity and value perception for the strategic advisors.

Future Outlook

The company is strategically expanding and diversifying its core business by integrating cryptocurrency and digital asset strategies into its product offerings and treasury management. This strategic shift is supported by the proposed equity issuances and the expansion of the equity incentive plan, which aims to attract and retain key talent in competitive markets. The Board believes these measures are crucial for long-term performance and growth.

Management Comments

• The Board unanimously recommends that you vote FOR the election of each director nominee and FOR Proposals 2, 3, 4 and 5.
• Your vote is extremely important, regardless of the number of shares of common stock you own.
• We use awards under the 2023 Equity Incentive Plan to attract and retain employees, ensure that our compensation program provides appropriate incentives to motivate our key employees, consultants, officers and non-employee directors to contribute to our long-term performance and growth, develop a culture of ownership and further align the interests of the participants and our stockholders.
• Our compensation program, including the granting of equity compensation, is a crucial way to attract and recruit new employees and consultants and retain existing employees and consultants, with equity compensation serving as our primary recruitment, retention and motivational tool as opposed to cash compensation.

Industry Context

Tharimmune is making a significant strategic pivot by integrating cryptocurrency and digital asset strategies into its business, moving beyond its traditional life sciences focus. This places the company in a highly competitive and rapidly evolving digital asset market, alongside its existing competitive landscape in life sciences. The emphasis on equity compensation reflects the intense competition for talent in both these high-growth sectors, indicating a need to offer attractive incentives to secure specialized expertise for its new strategic direction.

Comparison to Industry Standards

• No specific comparable companies, projects, or results are mentioned in the filing for direct industry comparison.

Management Changes

Corporate Governance

Related Party Transactions

• Mark Toomey (President) and Mark Wendland (Chief Executive Officer) are affiliated with DRW Canton Investments LLC, which is the Lead Strategic Advisor receiving Strategic Advisor Warrants.
• Mark Wendland (Chief Executive Officer) purchased 60,806 shares of Common Stock, 60,806 Series A Warrants, and 30,403 Series B Warrants in the June PIPE.
• Vincent LoPriore (Chairman of the Board) purchased 337,338 shares of Common Stock, 337,838 Series A Warrants, and 168,918 Series B Warrants in the June PIPE. He is affiliated with President Street Global, the placement agent for the June PIPE.
• Vincent LoPriore (Chairman of the Board) received a $2.05 million cash bonus in connection with the November PIPE.
• Sireesh Appajosyula (prior Interim Chief Financial Officer) received a $1.9 million cash bonus in connection with the November PIPE.

Stakeholder Impact

• Shareholders face potential significant dilution from the various warrant and RSU issuances and the expanded equity incentive plan, which could impact per-share value. However, the strategic pivot into digital assets could offer long-term growth potential if successfully executed.
• Employees, consultants, and directors stand to benefit from increased equity compensation opportunities (7,000,000 additional shares) designed to attract and retain talent, with new executives and directors receiving substantial compensation packages.
• Strategic advisors will receive warrants (5.0% of fully diluted common stock from an offering) for their services in guiding the company's digital asset strategy, contingent on shareholder approval.
• Clear Street LLC, as the placement agent, will receive Advisor RSUs (162,601 shares) for services rendered in the private placement offering, subject to shareholder approval.
• Creditors and investors in the PIPE financings will see the terms of their investments, including warrant and RSU issuances, ratified through the shareholder approval process, ensuring the fulfillment of agreements.

Next Steps

• Stockholders are requested to vote on the six proposals at the Special Meeting on January 30, 2026.
• If Proposal 1 is approved, two new directors will be elected to the Board.
• If Proposals 2, 3, and 4 are approved, shares underlying Strategic Advisor Warrants, Cryptocurrency Pre-Funded Warrants, and Advisor RSUs will become exercisable or settleable.
• If Proposal 5 is approved, the 2023 Omnibus Equity Incentive Plan will be amended to increase the number of available shares by 7,000,000.
• The company intends to announce preliminary voting results at the Special Meeting and publish final results in a Current Report on Form 8-K within four business days of the meeting.
• If the amendment to the equity incentive plan is approved, a registration statement on Form S-8 covering the added shares will be filed with the SEC.

Key Dates

Recommendation

The company is undergoing a significant strategic transformation by entering the cryptocurrency and digital asset space, which could be a long-term growth catalyst. The proposed board changes bring relevant expertise to support this shift. However, the substantial potential dilution from the various warrant and RSU issuances, coupled with a large increase in the equity incentive plan, presents a notable risk to existing shareholder value. Additionally, the significant cash bonuses to executives and related party transactions warrant careful consideration. A 'Hold' recommendation is appropriate as investors should monitor the execution of the new strategy and the impact of dilution before making further investment decisions.

Keywords

Tharimmune, THAR, proxy statement, special meeting, corporate governance, director election, equity incentive plan, stock options, restricted stock units, warrants, cryptocurrency, digital assets, Canton Coin, private placement, PIPE financing, Nasdaq listing rules, dilution, executive compensation, related party transactions